Argent Biopharma Ltd (ASX: RGT) Share Price and News
Price
$0.08
Movement
0.004 (+5.26%)
as at 10 Nov 11:47am (20 mins delayed)
52 Week Range
$0.068 - $0.32
1 Year Return
-72.41%
Argent Biopharma Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$0.08
Day Change
0.004 (+5.26%)
52 Week Range
$0.068 - $0.32
Yesterday's Close
$0.076
Today's Open
$0.075
Days Range
$0.075 - $0.08
Volume
29,632
Avg. Volume (1 month)
74,873
Turnover
$2,255
as at 10 Nov 11:47am
Argent Biopharma Ltd (ASX: RGT)
Latest News
Healthcare Shares
The MGC Pharmaceuticals (ASX:MXC) share price soared 20% today. Here's why
Healthcare Shares
MGC Pharmaceuticals (ASX:MXC) share price climbs on study approval
Healthcare Shares
Why the MGC Pharmaceuticals (ASX:MXC) share price is leaping 5%
Share Market News
What's going wrong for ASX cannabis shares lately?
Share Gainers
MGC Pharma (ASX:MXC) share price jumps 11% on UK approval
Share Market News
MGC Pharmaceuticals (ASX:MXC) share price rockets 40% on supply deal
Healthcare Shares
The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why
Share Gainers
Why the MGC Pharma (ASX:MXC) share price has rocketed 9%
Healthcare Shares
Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today
Share Market News
Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today
Share Market News
Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%
Share Market News
Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today
RGT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 31st Oct 2025 2025-10-31T19:15:46 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 7:15pm | 9 | 569k |
| 29th Oct 2025 2025-10-29T19:38:08 | Notice of Annual General Meeting/Proxy Form | YesNo | 7:38pm | 34 | 622k |
| 20th Oct 2025 2025-10-20T17:47:39 | Date of AGM and Closing Date for Director Nominations | YesNo | 5:47pm | 1 | 268k |
| 12th Sep 2025 2025-09-12T17:43:50 | s708A Cleansing Notice | YesNo | 5:43pm | 1 | 307k |
| 12th Sep 2025 2025-09-12T17:40:50 | Application for quotation of securities - RGT | YesNo | 5:40pm | 8 | 19k |
| 4th Sep 2025 2025-09-04T18:34:47 | s708A Cleansing Notice | YesNo | 6:34pm | 1 | 307k |
| 4th Sep 2025 2025-09-04T18:31:52 | Application for quotation of securities - RGT | YesNo | 6:31pm | 8 | 18k |
| 4th Sep 2025 2025-09-04T16:34:07 | Refinancing of Convertible Securities Agreement | YesNo | 4:34pm | 1 | 300k |
| 29th Aug 2025 2025-08-29T17:36:04 | Appendix 4G and Corporate Governance Statement | YesNo | 5:36pm | 26 | 700k |
| 29th Aug 2025 2025-08-29T17:35:39 | Appendix 4E and 2025 Annual Report | YesNo | 5:35pm | 68 | 2.8M |
About Argent Biopharma Ltd
MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.